These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 22963893)

  • 21. Cognitive functioning in patients with familial bipolar I disorder and their unaffected relatives.
    Antila M; Tuulio-Henriksson A; Kieseppä T; Eerola M; Partonen T; Lönnqvist J
    Psychol Med; 2007 May; 37(5):679-87. PubMed ID: 17181912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The neuropsychology of borderline personality disorder: relationship with clinical dimensions and comparison with other personality disorders.
    Seres I; Unoka Z; Bódi N; Aspán N; Kéri S
    J Pers Disord; 2009 Dec; 23(6):555-62. PubMed ID: 20001174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The neuropsychology of borderline personality disorder: a meta-analysis and review.
    Ruocco AC
    Psychiatry Res; 2005 Dec; 137(3):191-202. PubMed ID: 16297985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The association between attentional and executive controls in the expression of borderline personality disorder features: a preliminary study.
    Fertuck EA; Lenzenweger MF; Clarkin JF
    Psychopathology; 2005; 38(2):75-81. PubMed ID: 15802945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Borderline personality disorder and neuropsychological measures of executive function: A systematic review.
    McClure G; Hawes DJ; Dadds MR
    Personal Ment Health; 2016 Feb; 10(1):43-57. PubMed ID: 26381859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Shared executive dysfunctions in unaffected relatives of patients with autism and obsessive-compulsive disorder.
    Delorme R; Goussé V; Roy I; Trandafir A; Mathieu F; Mouren-Siméoni MC; Betancur C; Leboyer M
    Eur Psychiatry; 2007 Jan; 22(1):32-8. PubMed ID: 17127035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Similarities and differences in borderline and organic personality disorder.
    Mathiesen BB; Simonsen E; Soegaard U; Kvist K
    Cogn Neuropsychiatry; 2014; 19(1):1-16. PubMed ID: 23710758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deficits in visual functions and neuropsychological inconsistency in Borderline Personality Disorder.
    Beblo T; Saavedra AS; Mensebach C; Lange W; Markowitsch HJ; Rau H; Woermann FG; Driessen M
    Psychiatry Res; 2006 Dec; 145(2-3):127-35. PubMed ID: 17070927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Executive functioning in familial bipolar I disorder patients and their unaffected relatives.
    Schulze KK; Walshe M; Stahl D; Hall MH; Kravariti E; Morris R; Marshall N; McDonald C; Murray RM; Bramon E
    Bipolar Disord; 2011 Mar; 13(2):208-16. PubMed ID: 21443575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cognition in adults with borderline personality disorder.
    Aslan IH; Grant JE; Chamberlain SR
    CNS Spectr; 2023 Dec; 28(6):674-679. PubMed ID: 36924168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Response inhibition deficits in unaffected first-degree relatives of patients with borderline personality disorder.
    Ruocco AC; Laporte L; Russell J; Guttman H; Paris J
    Neuropsychology; 2012 Jul; 26(4):473-482. PubMed ID: 22612574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Executive attention deficits in schizophrenia: putative mandatory and differential cognitive pathology domains in medicated schizophrenia patients.
    Meiron O; Hermesh H; Katz N; Weizman A
    Psychiatry Res; 2013 Aug; 209(1):1-8. PubMed ID: 23102537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factorial validity, measurement equivalence and cognitive performance of the Cambridge Neuropsychological Test Automated Battery (CANTAB) between patients with first-episode psychosis and healthy volunteers.
    Haring L; Mõttus R; Koch K; Trei M; Maron E
    Psychol Med; 2015 Jul; 45(9):1919-29. PubMed ID: 25544472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intact implicit statistical learning in borderline personality disorder.
    Unoka Z; Vizin G; Bjelik A; Radics D; Nemeth D; Janacsek K
    Psychiatry Res; 2017 Sep; 255():373-381. PubMed ID: 28662479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Compliance on neuropsychological performance validity testing in patients with borderline personality disorder.
    Ruocco AC
    Psychol Assess; 2016 Mar; 28(3):345-350. PubMed ID: 26121384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The association between neurocognitive functioning and clinical features of borderline personality disorder.
    Kaplan B; Yazici Gulec M; Gica S; Gulec H
    Braz J Psychiatry; 2020; 42(5):503-509. PubMed ID: 32321061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Attention and executive functions in remitted major depression patients.
    Paelecke-Habermann Y; Pohl J; Leplow B
    J Affect Disord; 2005 Dec; 89(1-3):125-35. PubMed ID: 16324752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuropsychobiological aspects, comorbidity patterns and dimensional models in borderline personality disorder.
    Dell'Osso B; Berlin HA; Serati M; Altamura AC
    Neuropsychobiology; 2010; 61(4):169-79. PubMed ID: 20299811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of neuropsychological performance in Mexico City youth using the Cambridge Neuropsychological Test Automated Battery (CANTAB).
    Green R; Till C; Al-Hakeem H; Cribbie R; Téllez-Rojo MM; Osorio E; Hu H; Schnaas L
    J Clin Exp Neuropsychol; 2019 Apr; 41(3):246-256. PubMed ID: 30336715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How Informative Is the CANTAB to Assess Executive Functioning in Children With ADHD? A Controlled Study.
    Fried R; Hirshfeld-Becker D; Petty C; Batchelder H; Biederman J
    J Atten Disord; 2015 Jun; 19(6):468-75. PubMed ID: 22923781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.